- Training
- 60 Minutes
Global
- Report
- January 2025
- 126 Pages
Global
From €3500EUR$4,186USD£3,088GBP
- Report
- February 2024
- 97 Pages
Global
From €3500EUR$4,186USD£3,088GBP
- Report
- October 2023
- 146 Pages
Global
From €3717EUR$4,150USD£3,169GBP
- Report
- January 2024
- 132 Pages
Global
From €851EUR$950USD£725GBP
- Webinar
- February 2023
- 180 Minutes
Global
From €305EUR$340USD£260GBP
- Webinar
- March 2023
- 60 Minutes
Global
From €170EUR$190USD£145GBP
- Book
- July 2023
- 512 Pages
- Book
- July 2023
- 512 Pages
- Book
- February 2018
- 544 Pages
- Book
- February 2018
- 864 Pages
The Cell Based Assay market is a segment of the biotechnology industry that focuses on the development and use of cell-based assays for research and drug discovery. Cell-based assays are used to measure the effects of drugs, toxins, and other compounds on living cells. These assays are used to study the effects of drugs on cell growth, cell death, and gene expression. They are also used to study the effects of drugs on the immune system, metabolism, and other biological processes.
Cell-based assays are used in a variety of industries, including pharmaceuticals, biotechnology, and medical research. They are used to identify new drug targets, develop new drugs, and test the safety and efficacy of existing drugs.
Companies in the Cell Based Assay market include Thermo Fisher Scientific, Merck KGaA, Bio-Rad Laboratories, Promega Corporation, PerkinElmer, Inc., and Agilent Technologies. Show Less Read more
